Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:34:08.941Z.
Calculation as of: 2026-10-06T16:34:08.941Z.
Quote observation: 2026-10-06T16:30:43.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dfe3b7eb0a07bb41d8210bce1124860262d7a4d6e18a93ea2ad6da4bd4c55c28
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Praxis Precision Medicines, Inc.
Market Cap
$7.73B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.66B
Operating Cash Flow Yield
6.40%
TTM Avg
5.72%
3Y Avg
4.46%
5Y Avg
3.84%
Market Cap
$7.65B
Operating Cash Flow Yield
N/A
TTM Avg
0.47%
3Y Avg
0.47%
5Y Avg
2.01%
Market Cap
$7.61B
Operating Cash Flow Yield
3.82%
TTM Avg
3.97%
3Y Avg
3.54%
5Y Avg
3.54%
Market Cap
$7.93B
Operating Cash Flow Yield
2.54%
TTM Avg
2.52%
3Y Avg
2.52%
5Y Avg
2.52%
Market Cap
$7.33B
Operating Cash Flow Yield
N/A
TTM Avg
1.43%
3Y Avg
2.15%
5Y Avg
3.31%
Market Cap
$8.42B
Operating Cash Flow Yield
51.93%
TTM Avg
28.44%
3Y Avg
24.26%
5Y Avg
22.51%
Market Cap
$7.02B
Operating Cash Flow Yield
3.58%
TTM Avg
7.35%
3Y Avg
8.10%
5Y Avg
6.33%
Market Cap
$8.58B
Operating Cash Flow Yield
N/A
TTM Avg
3.45%
3Y Avg
3.46%
5Y Avg
3.46%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. (PRAX) | $7.73B | N/A | N/A | N/A | N/A |
| HealthEquity, Inc. (HQY)vs › | $7.66B | 6.40% | 5.72% | 4.46% | 3.84% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.65B | N/A | 0.47% | 0.47% | 2.01% |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | 3.82% | 3.97% | 3.54% | 3.54% |
| Caris Life Sciences, Inc. (CAI)vs › | $7.93B | 2.54% | 2.52% | 2.52% | 2.52% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.33B | N/A | 1.43% | 2.15% | 3.31% |
| Oscar Health, Inc. (OSCR)vs › | $8.42B | 51.93% | 28.44% | 24.26% | 22.51% |
| Alkermes plc (ALKS)vs › | $7.02B | 3.58% | 7.35% | 8.10% | 6.33% |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.58B | N/A | 3.45% | 3.46% | 3.46% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.77B | N/A | 2.18% | 2.18% | 2.46% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
